40 M n lay-Thursday,

40 DAIL Y PROGRAM
Montlay-Thursday, July 23-26, 1984
9:00-3:00
Convention Center, Exhibit Hall A
POSTER SESSION
1. 7 Familial Clustering of Salivary Gland Carcinoma in
Greenland. Y. Merrick, H. Albeck, and N. H. Nielsen. Copen-
hagen, Denmark.
2. 10 Chemotherapy tor Aggressive Juvenile Nasopharyn-
geaI Angiofibroma. H. Goepfert, A. Cangir, and A. Malekzadeh.
Houston, TX.
3. 16 Metastasis to the Vallecula of the Tongue îrom Cu-
taneous Malignant Melanoma. A. Routh, W. V. Morrison, and
B. T. Hickman. Jackson, MS.
4. 21 Soft Tissue Metastasis trom Carcinoma of the Floor
of the Mouth. A. Routh and B. T. Hickman. Jackson, MS.
5. 51 Carcinoma Arising in Median Ectopie Thyroid. L. P.
Rybak, W. Santiago, and R. M. Bass. Springfield, IL.
6. 59 Positive Correlation Between HLA B 27 and Larynx
Cancer. J. M. Deneufbourg and C. Bouillenne. Liege, Belgium.
7. 69 Characterization of Cell Subpopulations from Human
Head and Neck Squamous Cell Carcinomas. M. V. King,
D. F. Parsons, S. M. Parnes, J. C. Priee, and J. C. Goldstein.
Albany, NY.
8. 70 An Epithelial Organ Culture Model for Tumor Inter-
actions in Head and Neck Cancers. P. G. Sacks, J. C. Priee,
S. M. Parnes, J. C. Goldstein, H. Risemberg, and D. F. Parsons.
Albany, NY.
9. 74 Multimodality Therapy of Stage 1/1 and IV Squamous
Cell Carcinomas of the Head and Neck. J. D. Bitran and M.
Goldman. Chicago, IL.
10. 80 Anatomie Stabilization of the Remaining Mandible
with the Dynamic Morris Biphase Deviee After Extensive
Resections for Head and Neck Cancer. D. M. Morris and
B. D. Gross. Shreveport, LA.
11. 81 The Therapeutic Valueof Frozen Section Examination
and the Surgical Treatment of Skin Cancers of the Head
and Neck. H. Goepfert. Houston, TX.
12. 82 TheUse of Vasoactive Agents to Alter Regional Blood
Flow tn Patients with Head and Neck Cancer (H & N CA).
A. A. Forastiere, H. A. Ziessman, R. H. Wheeler, B. R. Medvec,
R. L. Wahl, J. E. Juni, and S. R. Baker. Ann Arbor, MI.
13. ii 1 Surgical-Prosthetic Reconstruction of Mid-Facial
Defects. W. R. Panje , W. H. LaVelie, and A. Fyler. Iowa City,
lA.
14·. 141 Reconstruction of Metachronous Midface Defects
in One Patient with Two Free Flaps. J. J. Coleman III.
Decatur, GA.
15. 156 Intraoperative Long-Latency Somatosensory Evoked
Cortical Potentiels in Evaluation of the Safety of Elective
Carotid Resection for Head and Neck Cancer. D. P. Atkinson,
L. A. Jacobs, and A. W. Weaver. Detroit, MI and Allen Park, MI.
16. i 64 Current Limitations of the ln Vitro Clonogenic Assay
ln Squamous Cell Carcinoma of the Head and Neck
(SCCHN). S. D. Archibald, G. P. Browman, M. Holmes. and S.
Jellie. Hamilton, Ontario, Canada.
'17. 178 CO
2
-Laser Evaporation of Orai l.eukoplskie: J_ L. N.
Roodenburg, A. K. Panders, A. Verrney, H. hl. Hadders, and
H. W. 8. Jansen. Groningen, The Nethenands.
18. 180 Preparation of Head and Neck Tumor Specimens
for Growth in Soft Agar and the Establishment of Cell
Lines. D. H. Libby, D. E. Schuller, S. E. Weisbrode, and G. E.
Milo. Columbus, OH.
19. 182 An Assessment of the Value of Triple Endoscopy in
the Evaluation of Head and Neck Cancer Patients. D. E.
Schuller. Columbus, OH.
20. 191 Establishment and Characteristics of Two Cell Lines
Derived from Cancers of the Oral Cavity. P. Chauvel, F.
Demard, J. Gioanni, A. Courdi, C. Philip, and C. M. Lalanne.
Nice, France.
21. 192 Intra-Arterial Chemotherapy in Head and Neck Can-
cers Results and Determination of Prognostic Factors. F.
Demard, M. Schneider, C. Philip, J. Vallicioni, and P. Chauvel.
Nice, France.
22. 250 Value of Computed Tomography in the Staging of
the Nasopharyngeal Cancers. P. Olmi, E. Cellai, A. Chiavacci,
and R. Fargnoli. Florence, Italy.
23. 252 VBM-Brachytherapy Combination vs. Other Com-
bined Therapeutic Approaches in the Treatment of 46 T2-
Large Oral Carcinomas. F. Volterrani, S. Tana, N. Trenti, and
A. Gramaglia. Milan, Italy.
24. 257 Warthin's Tumor-Associated Neoplasms. A. H.
Shikhana, l. J. Takla, C. K. Aliam, and M. A. Samara. Beirut,
Lebanon.
25. 265 Additional Brachytherapy in the Oropharynx Csrci-
noma (After Loading 192 Iridium Implant Using Plastic
Tubes). L. Malissard, M. Pernot, P. Bey, and S. Hoffstetter.
Nancy, France.
26. 296 Nasopharyngeal Carcinoma in Aigeria: Result of
Treatment and Correlations with Epstein Barr Virus Specific
Antibody. K. Boualga, R. Ghouadni, 1. Mokhteche, and D.
Ablashi. Algiers, Algeria and Bethesda, MD.
27. 300 Treatment of Squamous Cell Carcinoma of the Head
and Neck with Etoposide (VP-16). S. M. Grunberg, 1. E.
Felman, K. V. Gala, K. B. Johnson, and J. C. Owens. Los
Angeles, CA.
28. 301 Clinical Experience with Combined Chemotherapy,
Radiation Treatment and/or Surgical Therapy in Head and
Neck Tumors. H. W. Chin, Y. Maruyama, and M. H. Oison.
Lexington, KY.
29. 303 The Use of Toluidine Blue in the Diagnosis of
Asymptomatic Oral Carcinoma. H. A. Israel. New York, NY.
30. 316 Tumor of the Mandible and Differentiai Diagnosis
and Treatment in 24 Cases of Ameloblastoma. M. Riveros.
Asuncion, Paraguay.
31. 320 Immuno-Enzymic Detection of EBVCA-lgA Anfibody
in Sera and Middle Ear Effusion of Patients with Nasopha-
ryngeal Carcinoma and in Controls. T. Zheng-De, X. Jiang-
Yun, C. Hui-Ying, C_ Zhao-Zhen, Z. Zheng, and P. Yong-Yan.
Changsha, Hunan, PRC.
32. 321 Neurological Aspects of Nasopharyngeal Carcinoma.
T. Zheng-De. Changsha, Hunan, PRC.
33. 322 A Clinical Study of 1,298 Cases of Nasopharyngeal
Carcinoma. T. Zheng-De, L. Yuan-Bi n, and T_ Yong-Quan.
Changsha, Hunan, PRC.
34. 323 A Study of Preradiation and Postradiation Sponta-
neous Sister Chromatid Exchange Frequency in Peripheral
Lymphocytes of NPC Patients. T. Yonq-Ouan, P. Yang-Yan,
T. Zheng-De, and X. .lianq-Yun. Changsha, Hunan, PRC.
35. 324 Cancer of the Upper Respiï&Jory Tract in Libyan
Patients-A Tan Year Study. Shaflk A. Wassef and Sedil El
Retiemi. Tripoli, Libya.